Target intelligence / Profile preview

Protein phosphatase 1 regulatory subunit 15B (PPP1R15B)

Target
PPP1R15B
Molecular classification
Regulatory subunit of a serine/threonine phosphatase complex, Protein phosphatase regulatory protein, Other (regulatory subunit)
01

Overview

Protein phosphatase 1 regulatory subunit 15B (PPP1R15B) is a regulatory subunit that associates with the catalytic subunit of protein phosphatase 1 (PP1) to form a complex responsible for the dephosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2α), thus modulating protein synthesis, particularly under cellular stress conditions[1][5]. This regulation is critical for maintaining protein translation homeostasis, with stress-induced changes leading to a feedback loop for translation recovery. PPP1R15B also has roles independent of translation, such as in membrane trafficking and exocytosis. Genetic variants in PPP1R15B cause syndromes characterized by microcephaly, short stature, and metabolic defects. PPP1R15B is emerging as a cancer vulnerability in multiple myeloma, where its inhibition can activate stress pathways and synergize with anticancer agents[3].

Other names
FLJ14744CREPMSSGM2protein phosphatase 1 regulatory subunit 15Bprotein phosphatase 1, regulatory (inhibitor) subunit 15BPPP1R15B
02

Mechanism of action

Inhibition of PPP1R15B increases phosphorylation of eIF2α, driving activation of pro-apoptotic stress response pathways (such as eIF2α-ATF4-CHOP) and suppressing protein synthesis[3][5].

03

Biological functions

Regulation of eukaryotic translation initiationStress response regulationMaintenance of eIF2α (EIF2S1) dephosphorylation in unstressed cellsMembrane trafficking and exocytosis
04

Disease associations

MicrocephalyShort statureImpaired glucose metabolism (Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome)Cancer (evidence in multiple myeloma)Other (potential role in intellectual disability, erythropoiesis defects in animal models)
05

Safety considerations

Potential for widespread effects on protein synthesis and cellular stress responsesLoss of function mutations cause growth deficiency, microcephaly, impaired glucose metabolism, and in animal models, fatal erythropoiesis defects[1][5].Therapeutic inhibition could cause toxicity in rapidly dividing or stressed cells, and may affect normal development and homeostasis
06

Interacting drugs

Raphin1

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory subunit 15B (PPP1R15B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 15B (PPP1R15B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call